S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
NASDAQ:CLSN

Celsion Stock Forecast, Price & News

$0.87
-0.03 (-3.33 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.85
Now: $0.87
$0.92
50-Day Range
$0.57
MA: $0.72
$0.93
52-Week Range
$0.43
Now: $0.87
$6.50
Volume3.06 million shs
Average Volume3.13 million shs
Market Capitalization$32.56 million
P/E RatioN/A
Dividend YieldN/A
Beta2.42
Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.
Celsion logo

MarketRank

Overall MarketRank

1.29 out of 5 stars

Medical Sector

619th out of 1,556 stocks

Pharmaceutical Preparations Industry

313th out of 638 stocks

Analyst Opinion: 3.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CLSN
CUSIPN/A
Phone609-896-9100
Employees29

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$500,000.00
Book Value$0.63 per share

Profitability

Net Income$-16,850,000.00
Net Margins-4,315.00%

Miscellaneous

Market Cap$32.56 million
Next Earnings Date3/24/2021 (Estimated)
OptionableOptionable
$0.87
-0.03 (-3.33 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CLSN News and Ratings via Email

Sign-up to receive the latest news and ratings for CLSN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Celsion (NASDAQ:CLSN) Frequently Asked Questions

How has Celsion's stock price been impacted by Coronavirus?

Celsion's stock was trading at $0.99 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CLSN stock has decreased by 12.1% and is now trading at $0.87.
View which stocks have been most impacted by COVID-19
.

Is Celsion a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Celsion in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Celsion stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLSN, but not buy additional shares or sell existing shares.
View analyst ratings for Celsion
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Celsion?

Wall Street analysts have given Celsion a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Celsion wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Celsion's next earnings date?

Celsion is scheduled to release its next quarterly earnings announcement on Wednesday, March 24th 2021.
View our earnings forecast for Celsion
.

How were Celsion's earnings last quarter?

Celsion Co. (NASDAQ:CLSN) posted its quarterly earnings results on Sunday, November, 15th. The biotechnology company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by $0.11. The biotechnology company earned $0.13 million during the quarter, compared to the consensus estimate of $0.13 million. Celsion had a negative net margin of 4,315.00% and a negative return on equity of 104.32%.
View Celsion's earnings history
.

When did Celsion's stock split? How did Celsion's stock split work?

Celsion's stock reverse split before market open on Tuesday, May 30th 2017. The 1-14 reverse split was announced on Friday, May 26th 2017. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 26th 2017. An investor that had 100 shares of Celsion stock prior to the reverse split would have 7 shares after the split.

What price target have analysts set for CLSN?

2 Wall Street analysts have issued 1 year target prices for Celsion's stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate Celsion's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 359.8% from the stock's current price.
View analysts' price targets for Celsion
or view Wall Street analyst' top-rated stocks.

Who are some of Celsion's key competitors?

What other stocks do shareholders of Celsion own?

Who are Celsion's key executives?

Celsion's management team includes the following people:
  • Mr. Michael H. Tardugno, Exec. Chairman, Pres & CEO (Age 69, Pay $786.91k)
  • Mr. Jeffrey W. Church CPA, CPA, CFO, Exec. VP & Corp. Sec. (Age 63, Pay $455.92k)
  • Dr. Khursheed Anwer, Exec. VP & Chief Scientific Officer (Age 60, Pay $409.32k)
  • Dr. Nicholas Borys, Exec. VP & Chief Medical Officer (Age 61, Pay $505.98k)
  • Mr. Timothy J. Tumminello, Chief Accounting Officer & Controller (Age 62)
  • Ms. Marianne M. Lambertson, VP of Communications & Investor Relations

What is Celsion's stock symbol?

Celsion trades on the NASDAQ under the ticker symbol "CLSN."

How do I buy shares of Celsion?

Shares of CLSN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Celsion's stock price today?

One share of CLSN stock can currently be purchased for approximately $0.87.

How big of a company is Celsion?

Celsion has a market capitalization of $32.56 million and generates $500,000.00 in revenue each year. The biotechnology company earns $-16,850,000.00 in net income (profit) each year or ($0.91) on an earnings per share basis. Celsion employs 29 workers across the globe.

What is Celsion's official website?

The official website for Celsion is www.celsion.com.

How can I contact Celsion?

Celsion's mailing address is 997 LENOX DRIVE SUITE 100, LAWRENCEVILLE NJ, 08648. The biotechnology company can be reached via phone at 609-896-9100 or via email at [email protected]

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.